Skip to main content
NeuronFeed

Recursion · Series D

Pioneering AI-driven solutions in drug discovery to radically improve lives.

Amount

$239M

Round

Series D

Valuation

—

Announced

Sep 2020

Investors

Lead investor

Leaps by Bayer

Participating investors

Lux Capital Baillie Gifford Mubadala Investment Company
📎 Source

Other Recursion rounds

Date Round Amount
Apr 2021 IPO $436.4M Details →
Jul 2019 Series C $121M Details →
May 2017 Series B $60M Details →